Cyclizine-d3
Cyclizine-d3 is deuterium labeled Cyclizine. Cyclizine, a piperazine-derivative, is a potent and selective histamine H1 receptor antagonist. Cyclizine can be used for the research of nausea, vomiting, and dizziness[1][2][3][4].
Product Specifications
CAS Number
1170155-67-5
UNSPSC
12352005
Target
Histamine Receptor; Isotope-Labeled Compounds
Type
Isotope-Labeled Compounds
Related Pathways
GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling; Others
Field of Research
Neurological Disease
Smiles
[2H]C([2H])([2H])N(CC1)CCN1C(C2=CC=CC=C2)C3=CC=CC=C3
Molecular Formula
C18H19D3N2
Molecular Weight
269.40
References & Citations
[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53 (2) :211-216.|[2]Králová J, et, al. The effects of H1-antihistamines on the nitric oxide production by RAW 264.7 cells with respect to their lipophilicity. Int Immunopharmacol. 2009 Jul;9 (7-8) :990-5.|[3]Church MK, et, al. Inhibition of histamine release from human lung in vitro by antihistamines and related drugs. Br J Pharmacol. 1980 Aug;69 (4) :663-7.|[4]Leza JC, et, al. Effects of antihistaminics on locomotor activity in mice. Comparison with opiate and amphetamine-induced hyperactivity. Gen Pharmacol. 1991;22 (2) :293-6.
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC682858-500 1x 500 µL
CD3e (T-Cell Marker) (C3e/2858R), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC043081-500 1x 500 µL
Uroplakin 1B (Urothelial Differentiation Marker) (UPK1B/3081), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
